According to FibroGen's latest financial reports the company's current earnings are A$29.62 Million. , an increase over its 2023 earnings that were of -A$0.46 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 | -A$0.25 Billion | -46.54% |
2023 | -A$0.46 Billion | -2.71% |
2022 | -A$0.48 Billion | 1.44% |
2021 | -A$0.47 Billion | 53.87% |
2020 | -A$0.31 Billion | 146.49% |
2019 | -A$0.13 Billion | -11% |
2018 | -A$0.14 Billion | -20.84% |
2017 | -A$0.18 Billion | 76.16% |
2016 | -A$98.93 Million | -27.81% |
2015 | -A$0.14 Billion | 43.75% |
2014 | -A$95.33 Million |